These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 6114147

  • 1. On the mechanism of salicylate-induced hypothrombinaemia.
    Park BK, Leck JB.
    J Pharm Pharmacol; 1981 Jan; 33(1):25-8. PubMed ID: 6114147
    [Abstract] [Full Text] [Related]

  • 2. The effects of salicylate on enzymes of vitamin K metabolism.
    Hildebrandt EF, Suttie JW.
    J Pharm Pharmacol; 1983 Jul; 35(7):421-6. PubMed ID: 6136582
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A study of factors which determine the pharmacological response to vitamin K in coumarin anticoagulated rabbits.
    Hart JA, Haynes BP, Park BK.
    Biochem Pharmacol; 1984 Oct 01; 33(19):3013-9. PubMed ID: 6487353
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin K1 from vitamin K1 epoxide.
    Ren P, Stark PY, Johnson RL, Bell RG.
    J Pharmacol Exp Ther; 1977 Jun 01; 201(3):541-6. PubMed ID: 864593
    [Abstract] [Full Text] [Related]

  • 7. A study of the effect of anticoagulants on [3H]vitamin K1 metabolism and prothrombin complex activity in the rabbit.
    Park BK, Leck JB, Wilson AC, Serlin MJ, Breckenridge AM.
    Biochem Pharmacol; 1979 Apr 15; 28(8):1323-9. PubMed ID: 444299
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A fibroblast cell culture model to study vitamin K metabolism and the inhibition of vitamin K epoxide reductase by known and suspected antagonists.
    Ross PJ, Shearer MJ, Diplock AT, Schey SA.
    Br J Haematol; 1991 Feb 15; 77(2):195-200. PubMed ID: 2004021
    [Abstract] [Full Text] [Related]

  • 10. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin.
    Choonara IA, Malia RG, Haynes BP, Hay CR, Cholerton S, Breckenridge AM, Preston FE, Park BK.
    Br J Clin Pharmacol; 1988 Jan 15; 25(1):1-7. PubMed ID: 3370190
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Age-dependent differences in the effect of phenprocoumon on the vitamin K1-epoxide cycle in rats.
    Trenk D, Beermann D, Oesch F, Jähnchen E.
    J Pharm Pharmacol; 1980 Dec 15; 32(12):828-32. PubMed ID: 6110746
    [No Abstract] [Full Text] [Related]

  • 14. Enantiomers of warfarin and vitamin K1 metabolism.
    Choonara IA, Haynes BP, Cholerton S, Breckenridge AM, Park BK.
    Br J Clin Pharmacol; 1986 Dec 15; 22(6):729-32. PubMed ID: 3567019
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vitamin K epoxide reductase activity in the metabolism of epoxides.
    Liptay-Reuter I, Dose K, Guenthner T, Wörner W, Oesch F.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2617-20. PubMed ID: 4015704
    [Abstract] [Full Text] [Related]

  • 18. Changes in phylloquinone epoxidase activity related to prothrombin synthesis and microsomal clotting activity in the rat.
    Willingham AK, Matschiner JT.
    Biochem J; 1974 Jun 01; 140(3):435-41. PubMed ID: 4155625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.